Alliance for Automotive Innovation
EPARulemakingEPA-HQ-OPPT-2020-0744

n-Methylpyrrolidone (NMP); Rulemaking under TSCA Section 6(a)(CASRN 872-50-4)

RIN
Last modified
Sep 11, 2024
Comment window
closed 729d ago
Alliance for Automotive Innovation filings
1

Activity

Alliance for Automotive Innovation filed 1 comment on this docket between Jul 31, 2024 and Jul 31, 2024. 25 other organizations filed here. The comment window closed 729d ago.

What Alliance for Automotive Innovation filed (1)

Jul 31, 2024· Comment submitted by Alliance for Automotive Innovation· EPA-HQ-OPPT-2020-0744-0296

Filed on regulations.gov — full text not in the inline record.

Abstract

Section 6 of the Toxic Substances Control Act (TSCA) requires EPA to address unreasonable risks that the Administrator has determined are presented by a chemical substance under the conditions of use. Following a risk evaluation carried out under the authority of TSCA section 6, EPA has determined that n-methylpyrrolidone (NMP) (CASRN 872-50-4) presents unreasonable risks of injury to health. EPA is initiating rulemaking under TSCA section 6 to address these unreasonable risks.

View on regulations.gov →
n-Methylpyrrolidone (NMP); Rulemaking under TSCA Section 6(a)(CASRN 872-50-4) (EPA) — Alliance for Automotive Innovation | OpenPolis